Moody Aldrich Partners’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-18,200
Closed -$860K 111
2018
Q3
$860K Buy
+18,200
New +$860K 0.25% 88